Lunch Webinar Discussion 'Why invest in Healthcare Innovations?'
Are we entering a ‘golden era’ of health care innovation? Breakthroughs in genomic sequencing and data processing are enabling highly targeted and precise interventions. Biopharma appears to be in the midst of this wave of innovation.
At the same time, biopharmaceutical innovations are coinciding with lightning-fast developments in AI. Together they are paving the way for new treatments for far-reaching diseases worldwide, such as obesity and other chronic metabolic diseases.
- How do technological innovations in healthcare translate into investment opportunities?
- What are the risks?
- How is AI driving innovation and developments within the sector?
- What kind of companies are set to benefit in the long term?
- How to approach the sector in your investment portfolio?
On September 3rd 2024, Financial Investigator hosted a Lunch Webinar Discussion on 'Why invest in Healthcare Innovations?'.
Harry Geels, Senior Investment Advisor at Auréus, posed (critical) questions to Laura Nelson Carney, Investment Analyst Biotech/Pharma at Capital Group.
Watch the video here: